Cartesian Therapeutics Stock Technical Analysis
| RNAC Stock | 7.48 0.12 1.58% |
As of the 5th of March, Cartesian Therapeutics shows the Mean Deviation of 3.57, downside deviation of 4.63, and Risk Adjusted Performance of 0.0316. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Cartesian Therapeutics, as well as the relationship between them.
Cartesian Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cartesian, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CartesianCartesian | Build AI portfolio with Cartesian Stock |
Cartesian Therapeutics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 35.57 | Strong Buy | 8 | Odds |
Most Cartesian analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cartesian stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cartesian Therapeutics, talking to its executives and customers, or listening to Cartesian conference calls.
Will Biotechnology sector continue expanding? Could Cartesian diversify its offerings? Factors like these will boost the valuation of Cartesian Therapeutics. Anticipated expansion of Cartesian directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cartesian Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.07) | Earnings Share (1.33) | Revenue Per Share | Quarterly Revenue Growth 0.168 | Return On Assets |
The market value of Cartesian Therapeutics is measured differently than its book value, which is the value of Cartesian that is recorded on the company's balance sheet. Investors also form their own opinion of Cartesian Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cartesian Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Cartesian Therapeutics' market value can be influenced by many factors that don't directly affect Cartesian Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cartesian Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cartesian Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cartesian Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cartesian Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cartesian Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cartesian Therapeutics.
| 12/05/2025 |
| 03/05/2026 |
If you would invest 0.00 in Cartesian Therapeutics on December 5, 2025 and sell it all today you would earn a total of 0.00 from holding Cartesian Therapeutics or generate 0.0% return on investment in Cartesian Therapeutics over 90 days. Cartesian Therapeutics is related to or competes with Eupraxia Pharmaceuticals, Inventiva, Nautilus Biotechnology, Orchestra BioMed, Mediwound, Aardvark Therapeutics, and Fennec Pharmaceuticals. Cartesian Therapeutics is entity of United States More
Cartesian Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cartesian Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cartesian Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.63 | |||
| Information Ratio | 0.0218 | |||
| Maximum Drawdown | 28.9 | |||
| Value At Risk | (8.19) | |||
| Potential Upside | 7.64 |
Cartesian Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cartesian Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cartesian Therapeutics' standard deviation. In reality, there are many statistical measures that can use Cartesian Therapeutics historical prices to predict the future Cartesian Therapeutics' volatility.| Risk Adjusted Performance | 0.0316 | |||
| Jensen Alpha | 0.145 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.0232 | |||
| Treynor Ratio | (1.49) |
Cartesian Therapeutics March 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0316 | |||
| Market Risk Adjusted Performance | (1.48) | |||
| Mean Deviation | 3.57 | |||
| Semi Deviation | 4.48 | |||
| Downside Deviation | 4.63 | |||
| Coefficient Of Variation | 3253.01 | |||
| Standard Deviation | 4.93 | |||
| Variance | 24.35 | |||
| Information Ratio | 0.0218 | |||
| Jensen Alpha | 0.145 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.0232 | |||
| Treynor Ratio | (1.49) | |||
| Maximum Drawdown | 28.9 | |||
| Value At Risk | (8.19) | |||
| Potential Upside | 7.64 | |||
| Downside Variance | 21.41 | |||
| Semi Variance | 20.04 | |||
| Expected Short fall | (3.95) | |||
| Skewness | 0.3559 | |||
| Kurtosis | 1.78 |
Cartesian Therapeutics Backtested Returns
Cartesian Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Cartesian Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0522, which signifies that the company had a 0.0522 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Cartesian Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Cartesian Therapeutics' Risk Adjusted Performance of 0.0316, downside deviation of 4.63, and Mean Deviation of 3.57 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Cartesian Therapeutics holds a performance score of 4. The firm shows a Beta (market volatility) of -0.0953, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Cartesian Therapeutics are expected to decrease at a much lower rate. During the bear market, Cartesian Therapeutics is likely to outperform the market. Please check Cartesian Therapeutics' skewness, day typical price, and the relationship between the downside variance and daily balance of power , to make a quick decision on whether Cartesian Therapeutics' price patterns will revert.
Auto-correlation | 0.47 |
Average predictability
Cartesian Therapeutics has average predictability. Overlapping area represents the amount of predictability between Cartesian Therapeutics time series from 5th of December 2025 to 19th of January 2026 and 19th of January 2026 to 5th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cartesian Therapeutics price movement. The serial correlation of 0.47 indicates that about 47.0% of current Cartesian Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.47 | |
| Spearman Rank Test | 0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.27 |
Cartesian Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cartesian Therapeutics Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Cartesian Therapeutics across different markets.
About Cartesian Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cartesian Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cartesian Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cartesian Therapeutics price pattern first instead of the macroeconomic environment surrounding Cartesian Therapeutics. By analyzing Cartesian Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cartesian Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cartesian Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 2.67 | 0.54 | 0.62 | 0.59 | Revenue Per Share | 5.03 | 1.5 | 1.73 | 1.64 |
Cartesian Therapeutics March 5, 2026 Technical Indicators
Most technical analysis of Cartesian help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cartesian from various momentum indicators to cycle indicators. When you analyze Cartesian charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0316 | |||
| Market Risk Adjusted Performance | (1.48) | |||
| Mean Deviation | 3.57 | |||
| Semi Deviation | 4.48 | |||
| Downside Deviation | 4.63 | |||
| Coefficient Of Variation | 3253.01 | |||
| Standard Deviation | 4.93 | |||
| Variance | 24.35 | |||
| Information Ratio | 0.0218 | |||
| Jensen Alpha | 0.145 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.0232 | |||
| Treynor Ratio | (1.49) | |||
| Maximum Drawdown | 28.9 | |||
| Value At Risk | (8.19) | |||
| Potential Upside | 7.64 | |||
| Downside Variance | 21.41 | |||
| Semi Variance | 20.04 | |||
| Expected Short fall | (3.95) | |||
| Skewness | 0.3559 | |||
| Kurtosis | 1.78 |
Cartesian Therapeutics March 5, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Cartesian stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.05 | ||
| Daily Balance Of Power | (0.32) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 7.34 | ||
| Day Typical Price | 7.39 | ||
| Price Action Indicator | 0.08 | ||
| Market Facilitation Index | 0.38 |
Complementary Tools for Cartesian Stock analysis
When running Cartesian Therapeutics' price analysis, check to measure Cartesian Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cartesian Therapeutics is operating at the current time. Most of Cartesian Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cartesian Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cartesian Therapeutics' price. Additionally, you may evaluate how the addition of Cartesian Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |